Frontiers in Medicine,
Journal Year:
2024,
Volume and Issue:
11
Published: Dec. 18, 2024
ACE2
and
TMPRSS2
represent
the
major
gateways
for
SARS-CoV-2
cell
entry.
The
presence
of
functional
genetic
polymorphisms
that
affect
gene
expression
may
risk
severe
form
COVID-19
its
fatal
outcome.
Nature Communications,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: Jan. 29, 2024
Abstract
The
constant
emergence
of
SARS-CoV-2
variants
continues
to
impair
the
efficacy
existing
neutralizing
antibodies,
especially
XBB.1.5
and
EG.5,
which
showed
exceptional
immune
evasion
properties.
Here,
we
identify
a
highly
conserved
epitope
targeted
by
broad-spectrum
antibody
BA7535,
demonstrates
high
neutralization
potency
against
not
only
previous
variants,
such
as
Alpha,
Beta,
Gamma,
Delta
Omicron
BA.1-BA.5,
but
also
more
recently
emerged
subvariants,
including
BF.7,
CH.1.1,
XBB.1,
XBB.1.5,
XBB.1.9.1,
EG.5.
Structural
analysis
Spike
trimer
with
BA7535-Fab
using
cryo-EM
indicates
that
BA7535
recognizes
cryptic
receptor-binding
domain
(RBD)
epitope,
avoiding
most
mutational
hot
spots
in
RBD.
Furthermore,
structural
simulation
based
on
interaction
BA7535-Fab/RBD
complexes
dissects
broadly
effect
latest
variants.
Therapeutic
prophylactic
treatment
alone
or
combination
BA7208
protected
female
mice
from
circulating
BA.5
XBB.1
variant
infection,
suggesting
serves
potential
target
for
developing
potent
therapeutic
antibodies
vaccines.
Vaccines,
Journal Year:
2023,
Volume and Issue:
11(9), P. 1502 - 1502
Published: Sept. 19, 2023
The
COVID-19
pandemic
has
been
met
with
an
unprecedented
response
from
the
scientific
community,
leading
to
development,
investigation,
and
authorization
of
vaccines
antivirals,
ultimately
reducing
impact
SARS-CoV-2
on
global
public
health.
However,
is
far
being
eradicated,
continues
evolve,
causes
substantial
health
economic
burdens.
In
this
narrative
review,
we
posit
essential
points
its
responsible
management
during
transition
acute
phase
pandemic.
As
discussed,
despite
Omicron
(sub)variant(s)
causing
clinically
milder
infections,
a
negligible
pathogen.
It
requires
continued
genomic
surveillance,
particularly
if
one
considers
that
future
(sub)lineages
do
not
necessarily
have
be
milder.
Antivirals
remain
elements
in
management.
former
could
benefit
further
development
improvements
dosing,
while
seasonal
administration
latter
simplification
increase
interest
tackle
vaccine
hesitancy.
also
ensure
accessibility
pharmaceuticals
low-income
countries
improve
understanding
their
use
context
long-term
goals
Regardless
location,
primary
role
awareness
education
must
played
by
healthcare
workers,
who
directly
communicate
patients
serve
as
models
for
healthy
behaviors.
The Lancet Regional Health - Europe,
Journal Year:
2023,
Volume and Issue:
35, P. 100755 - 100755
Published: Oct. 26, 2023
Since
the
first
emergence
of
Omicron
BA.1
in
England
November
2021,
numerous
sub-lineages
have
evolved.
In
September
2022,
BA.5
dominated.
The
prevalence
BQ.1
increased
from
October,
while
CH.1.1
and
XBB.1.5
December
2022
January
2023,
respectively.
Little
is
known
about
effectiveness
vaccines
against
hospitalisation
with
these
sub-lineages,
nor
relative
severity,
so
we
here
used
national-level
electronic
health
records
to
estimate
vaccine
variant
severity.
Scientific Reports,
Journal Year:
2024,
Volume and Issue:
14(1)
Published: Jan. 5, 2024
Abstract
The
growing
occurrence
of
novel
recombinants,
such
as
XBB.1.16,
has
emerged
and
become
predominant,
raising
concerns
about
the
impact
genomic
recombination
on
evolution
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2).
This
study
investigated
molecular
epidemiological
trends
Omicron
XBB.1.16
epidemic
in
Bangkok
between
December
2022
August
2023.
Partial
spike
complete
genome
sequencing
SARS-CoV-2
samples
collected
from
collaborating
hospitals
were
performed.
analysis
491
partial
sequences
identified
15
distinct
lineages,
with
dominating
lineages
beginning
March
Phylogenetic
revealed
at
least
four
suggesting
multiple
independent
introductions
into
Bangkok.
estimated
emergence
occurred
approximately
January
2022,
an
evolutionary
rate
0.79
×
10
–3
substitutions
per
site
year.
Monitoring
epidemiology
is
vital
for
early
detection
new
strains
or
emerging
variants,
which
may
guide
vaccine
design
inclusion
strains.
Vaccines,
Journal Year:
2024,
Volume and Issue:
12(8), P. 887 - 887
Published: Aug. 5, 2024
Beginning
in
2022,
following
widespread
infection
and
vaccination
among
the
global
population,
SARS-CoV-2
virus
mainly
evolved
to
evade
immunity
derived
from
vaccines
past
infections.
This
review
covers
convergent
evolution
of
structural,
nonstructural,
accessory
proteins
SARS-CoV-2,
with
a
specific
look
at
common
mutations
found
long-lasting
infections
that
hint
potentially
reverting
an
enteric
sarbecovirus
type.
Frontiers in Public Health,
Journal Year:
2025,
Volume and Issue:
13
Published: Feb. 27, 2025
The
emergence
of
new
SARS-CoV-2
variants
makes
it
difficult
to
forecast
potential
epidemiological
changes.
This
study
investigates
Saudi
citizens'
perceptions
COVID-19
during
the
Omicron
wave.
We
conducted
a
cross-sectional
using
an
online
survey
and
convenience
sample
746
participants.
included
questions
about
demographics,
anxiety
levels,
perception
Our
findings
revealed
that
27.3%
participants
believed
cases
would
decrease,
while
30.2%
increase;
remaining
42.5%
were
uncertain.
When
asked
primary
reasons
for
expecting
rise
in
cases,
two
most
frequently
cited
causes
non-adherence
prevention
measures
(74.7%)
high
transmissibility
virus
(66.7%).
Conversely,
when
decrease
availability
free
vaccines
(60.3%),
government
(59.9%),
compliance
with
preventive
(57.4%),
health
awareness
programs
(44.1%).
Multivariate
logistic
regression
analysis
indicated
(AOR
=
1.23,
95%
CI:
1.15-1.32)
education
level
1.58,
1.11-2.25)
significant
predictors
respondents'
expectations
increases
or
decreases
(p
<
0.05).
Around
46.2%
moderately
highly
worried
reinstatement
lockdowns,
36.2%
reported
moderate
levels
related
COVID-19.
Ordinal
showed
respondents
who
higher
worry
lockdowns
1.28
times
more
likely
experience
A
few
hesitant
adhere
because
they
had
already
been
vaccinated
was
not
real
severe.
hesitancy
raises
public
concerns,
suggesting
some
individuals
may
underestimate
risks
associated
future
pandemics.
provides
valuable
insights
into
how
citizens
perceived
Understanding
these
can
guide
development
policies,
optimize
resource
allocation,
help
control
transmission
viral
variants,
enhance
preparedness
The Journal of Infectious Diseases,
Journal Year:
2024,
Volume and Issue:
230(5), P. 1197 - 1201
Published: July 18, 2024
Abstract
Within
a
multistate
viral
genomic
surveillance
program,
we
evaluated
whether
proportions
of
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
infections
attributed
to
the
JN.1
variant
and
XBB-lineage
variants
(including
HV.1
EG.5)
differed
between
inpatient
outpatient
care
settings
during
periods
cocirculation.
Both
were
less
likely
than
EG.5
account
for
among
inpatients
versus
outpatients
(adjusted
odds
ratio
[aOR],
0.60
[95%
confidence
interval
(CI),
.43–.84;
P
=
.003]
0.35
[.21–.58;
<
.001],
respectively).
may
be
associated
with
lower
risk
illness.
The
severity
disease
2019
have
attenuated
as
predominant
circulating
SARS-CoV-2
lineages
shifted
from
JN.1.